Beranda › Purpura Trombositopenik Idiopatik › California
Uji klinis Purpura Trombositopenik Idiopatik di California
10 studi untuk Purpura Trombositopenik Idiopatik mencari peserta di lokasi di California.
Kota di California
Teks studi resmi (Bahasa Inggris)
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
- USC Norris Comprehensive Cancer Center, Los Angeles
- Stanford University, Palo Alto
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06721013A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
- University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT06722235A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)
- MemorialCare Long Beach Medical Center, Long Beach
Menerima pesertaFase 3
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07700238Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
- Usc Norris Comprehensive Cancer Center, Los Angeles
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07104565A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)
- University of Southern California, Los Angeles
Menerima pesertaFase 3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07059000A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
- University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06948318OM336 in Autoimmune Cytopenias
- City of Hope, Duarte
Menerima pesertaFase 1
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07083960Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- University of California-Irvine, Orange
Menerima pesertaFase 1
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT06371417Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
- Community Health Partners (CHP) - Community Medical Oncology Specialists (University Oncology Associates), Clovis
- University of Southern California (USC), Los Angeles
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Jun 2026 · NCT07007962A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
- University of Southern California Norris Comprehensive Cancer Center, Los Angeles
- Sharp Memorial Hospital, Oceanside
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Mei 2026 · NCT06544499Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.